"Fungemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
| Descriptor ID |
D016469
|
| MeSH Number(s) |
C01.539.757.360 C01.703.492.625 C23.550.470.790.500.360
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Fungemia".
Below are MeSH descriptors whose meaning is more specific than "Fungemia".
This graph shows the total number of publications written about "Fungemia" by people in this website by year, and whether "Fungemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 1 | 0 | 1 |
| 2004 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 8 | 3 | 11 |
| 2018 | 6 | 3 | 9 |
| 2019 | 2 | 0 | 2 |
| 2020 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Fungemia" by people in Profiles.
-
Pacemaker-related Candida parapsilosis fungaemia in an immunosuppressed renal transplant recipient. BMJ Case Rep. 2021 Jul 06; 14(7).
-
Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids. Mycoses. 2021 Aug; 64(8):817-822.
-
Fungemia in COVID-19 ICU patients, a single medical center experience. J Med Virol. 2021 May; 93(5):2810-2814.
-
COVID-19-associated takotsubo cardiomyopathy. BMJ Case Rep. 2020 Dec 12; 13(12).
-
Risks and features of secondary infections in severe and critical ill COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):1958-1964.
-
Incidence of bacterial and fungal bloodstream infections in COVID-19 patients in intensive care: An alarming "collateral effect". J Glob Antimicrob Resist. 2020 12; 23:290-291.
-
Long-term risk of hepatocellular carcinoma mortality in 23220 hospitalized patients treated with micafungin or other parenteral antifungals. J Antimicrob Chemother. 2020 01 01; 75(1):221-228.
-
Breakthrough bloodstream infections in critically ill non-neutropenic patients: higher incidence and better survival than non-breakthrough infections. J Med Microbiol. 2019 Oct; 68(10):1544-1551.
-
A case report of fungemia due to Kodamaea ohmeri. BMC Infect Dis. 2019 Jul 01; 19(1):570.
-
Metagenomics to Assist in the Diagnosis of Bloodstream Infection. J Appl Lab Med. 2019 01; 3(4):643-653.